Koo Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
1. Auflage 2019
ISBN: 978-3-030-31000-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 113 Seiten
Reihe: Biomedical and Life Sciences (R0)
ISBN: 978-3-030-31000-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management.- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout.- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets.- Amplification-Free Electrochemical RNA Biomarker Sensing.- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.
